SCHEMBL7174147

SCHEMBL7174147

O=C(Nc1ccc2c(c1)CCC2)NC1CCN(C/C2=C\CCCCCC2)CC1

nearest known ligand 0.74

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CXCR3 P49682 14/20 0.74
CYP2D6 P10635 1/20 0.74
CCR1 P32246 3/20 0.52
ALOX5 P09917 1/20 0.47
EPHX2 P34913 1/20 0.47
DRD2 P14416 1/20 0.46
DRD4 P21917 1/20 0.46
DRD3 P35462 1/20 0.46
KMT2A Q03164 1/20 0.46
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7174149 1.00 CXCR3 (0.74) CXCR3CYP2D6CCR1ALOX5EPHX2
SCHEMBL7174143 1.00 CXCR3 (0.74) CXCR3CYP2D6CCR1ALOX5EPHX2
SCHEMBL6313752 0.86 CXCR3 (0.77) CXCR3CYP2D6CCR1EPHX2NPC1
SCHEMBL6313755 0.86 CXCR3 (0.77) CXCR3CYP2D6CCR1EPHX2NPC1
SCHEMBL6313749 0.86 CXCR3 (0.77) CXCR3CYP2D6CCR1EPHX2NPC1
SCHEMBL22965169 0.85 CXCR3 (1.00) CXCR3CYP2D6CCR1EPHX2
SCHEMBL6314461 0.84 CXCR3 (0.75) CXCR3CYP2D6CCR1EPHX2NPC1
SCHEMBL6314469 0.84 CXCR3 (0.75) CXCR3CYP2D6CCR1EPHX2NPC1
SCHEMBL6314473 0.84 CXCR3 (0.75) CXCR3CYP2D6CCR1EPHX2NPC1
SCHEMBL6320011 0.83 CXCR3 (0.70) CXCR3CYP2D6CCR1EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1478359-A1 PIPERIDIN-4-YL UREA DERIVATIVES AND RELATED COMPOUNDS AS CHEMOKINE RECEPTOR INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES Celltech R & D Limited (GB) 2004-11-24 EP disclosed
WO-2003070242-A1 PIPERIDIN-4-YL UREA DERIVATIVES AND RELATED COMPOUNDS AS CHEMOKINE RECEPTOR INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES CELLTECH R & D LIMITED (GB) 2003-08-28 WO disclosed